FR1604144A - Cerebrospinal meningitis vaccine - Google Patents
Cerebrospinal meningitis vaccineInfo
- Publication number
- FR1604144A FR1604144A FR1604144DA FR1604144A FR 1604144 A FR1604144 A FR 1604144A FR 1604144D A FR1604144D A FR 1604144DA FR 1604144 A FR1604144 A FR 1604144A
- Authority
- FR
- France
- Prior art keywords
- vaccine
- organisms
- billion
- cultures
- cerebrospinal meningitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Vaccine against human cerebrospinal meningitis. Microbial strains isolated during an epidemic are separately cultured in vitro by conventional methods, then passaged (48 hrs) several times (pref. 5-6) in the allantoic cavity of the 7-10 day-old chick embryo. Subcultures of the allantoic fluid are used to inoculate industrial cultures. The product is centrifuged, the microbial pellet resuspended, the organisms inactivated (heat, phenol, CH2O, etc.) and then made up into vaccine doses (5-30 strains) contng. 10 billion dead organisms in 0.1 ml., finally lyophilised. Concd. cultures can be obtd., e.g. 500-100 billion organisms per ml., permitting a single intradermal injection of 0.1 ml. of vaccine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR137847 | 1968-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR1604144A true FR1604144A (en) | 1971-07-12 |
Family
ID=8645254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1604144D Expired FR1604144A (en) | 1968-01-29 | 1968-01-29 | Cerebrospinal meningitis vaccine |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE1904001A1 (en) |
| FR (1) | FR1604144A (en) |
| OA (1) | OA03309A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08505128A (en) * | 1992-10-26 | 1996-06-04 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ リプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Immunization against Neisseria gonorrhoeae and Neisseria meningitidis |
-
1968
- 1968-01-29 FR FR1604144D patent/FR1604144A/en not_active Expired
-
1969
- 1969-01-17 OA OA53480A patent/OA03309A/en unknown
- 1969-01-28 DE DE19691904001 patent/DE1904001A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE1904001A1 (en) | 1969-10-02 |
| OA03309A (en) | 1970-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES408766A1 (en) | Process for preparing vaccine adjuvant | |
| GB1501724A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| FR1604144A (en) | Cerebrospinal meningitis vaccine | |
| OA09865A (en) | Preparation and use of formalin-killed colonization-factor-antigen (CFA)-expressing E. Coli Organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic E. Coli bacteria in humans. | |
| ES421549A1 (en) | Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof | |
| GB1292803A (en) | Improvements relating to the production of antigens | |
| GB1290141A (en) | ||
| GB1354075A (en) | Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same | |
| ES379642A1 (en) | Diethylaminoethyl dextran as an adjuvant for vaccines for active immunization | |
| IE38555L (en) | Colibacillosis vaccines. | |
| DE2962921D1 (en) | Feline infectious peritonitis vaccine and process for its preparation | |
| GB1390467A (en) | Vaccination method using temperature sensitive virus mutants | |
| GB1399782A (en) | Vaccines for immunization against kennel cough | |
| FR2230346A1 (en) | Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposes | |
| SU661017A1 (en) | B-73 chlamudiaegnis strain | |
| FR2047886A1 (en) | Non-toxic anti-whooping cough vaccine | |
| Fox | In search of a better typhoid vaccine. | |
| ES392830A1 (en) | Vaccine against typhoid fever and process for the production thereof | |
| Sheep | In Vitro Preparation And Testing Of Anti-Salmonella | |
| GB1239354A (en) | ||
| GB1206718A (en) | Vaccine for use against brucelloses | |
| GB770852A (en) | Vaccine products and process of producing the same | |
| ES345151A1 (en) | New Lactic Ferment | |
| BG50962A1 (en) | Method of producing live lyophilied vaccine against infection caused by salmonella typhimurium | |
| GB1439742A (en) | Live influenza type b virus vaccines and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |